• Awiqli® offers adults with type 2 diabetes an alternative to daily basal insulin injections, reducing frequency of these weekly basal injections from seven to one per week1
  • Awiqli® will be available at over 70,000 pharmacies nationwide
  • Affordability programs can be found through NovoCare.com, where eligible patients can pay as little as $35 per month